KRISTAL WATKINS: Open Payments
NPI 1144848383 · CLINTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 25 payments from 12 companies in 2025. Trend: 2023 $1,358 · 2024 $1,291 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
Products named: NURTEC ODT, CAPLYTA, ELIQUIS, GIVLAARI, JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, Ozempic.
Industry payments across TN — which companies pay providers there.
